Zurueck zur Suche

Reporte zur Charge UJ600AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KS 1 MI 1 TX 1 OH 1 PA 1

VAERS 2410894

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AA

mild
Staat
KS
Alter
0,3
Geschlecht
F
Eingang
13.08.2022
Impfdatum
11.08.2022
Beginn
11.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Breast feeding Injection site urticaria Swelling Urticaria

Symptomtext

Approximately 4 hours after immunizations, mother noticed two small hives to infants cheek, before bedtime. By the next morning, infants arms and legs had several small raised wheals to them, consistent with hives. Infant was brought into urgent care clinic to be evaluated the next morning after immunizations. No signs or symptoms of anaphylaxis or angioedema was noted. Child was breastfeeding without difficulty, respirations were even and unlabored. Exam was unremarkable with the exception of the hives noted above. No prior reactions with previous immunizations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site urticaria
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
RSV diagnosed on 7/18/22
Vorgeschichte
None
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2583422

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AA

gering
Staat
MI
Alter
1,3
Geschlecht
M
Eingang
17.02.2023
Impfdatum
31.10.2022
Beginn
31.10.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

DOSE THAT WAS GIVEN WAS EXPIRED BY 2DAYS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2565000

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AA

gering
Staat
TX
Alter
0,8
Geschlecht
M
Eingang
21.01.2023
Impfdatum
11.01.2023
Beginn
11.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

expired dose of act-hib was given to a 9-year-old male patient with no reported adverse event; Initial information was received on 13-Jan-2023 regarding an unsolicited valid non-serious case received from a consumer/non-health-care professional. This case involves 9 months old male patient who experienced expired dose of act-hib was given to a 9-year-old male patient with no reported adverse event while receiving vaccine hib (prp/t) vaccine [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included pneumococcal vaccine CONJ 7V (CRM197) (PREVNAR) for Prophylactic vaccination; DIPHTHERIA VACCINE TOXOID, hepatitis b vaccine RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID (Pediarix) for Prophylactic vaccination; and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (Rotateq) for Prophylactic vaccination. On 11-Jan-2023, the patient received a dose of suspect hib (prp/t) Powder and solvent for solution for injection vaccine at dose of 0.5 ml lot UJ600AA via intramuscular route in the left thigh. On 11-Jan-2023 the patient developed a non-serious event of expired dose of act-hib was given to a 9-year-old male patient with no reported adverse event (expired product administered) following the administration of hib (prp/t) vaccine. Action taken with haemophilus type b (hib) vaccine (ACT-HIB) was not applicable. It was not reported if the patient received a corrective treatment for the event (expired dose of act-hib was given to a 9-year-old male patient with no reported adverse event). At time of reporting, the outcome was Unknown for the event expired dose of act-hib was given to a 9-year-old male patient with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2551947

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AA

gering
Staat
OH
Alter
2,0
Geschlecht
F
Eingang
06.01.2023
Impfdatum
28.12.2022
Beginn
28.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

administered an expired ACTHIB to a patient with no reported adverse event; Initial information received on 03-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 year old female patient who experienced administered an expired acthib to a patient with no reported adverse event after receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Dec-2022, the patient received a 0.5 ml dose of suspect HIB (PRP/T) VACCINE for Powder and solvent for solution for injection (frequency: 1 day) (lot: UJ600AA, expiry date: 30-Nov-2022, strength: unknown) via intramuscular route in the left thigh for immunization. On 28-DEC-2022 (latency: 1 day) the patient developed a non-serious administered an expired acthib to a patient with no reported adverse event (expired product administered) following the administration of HIB (PRP/T) VACCINE. No lab test available. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2463125

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AA

gering
Staat
-
Alter
0,4
Geschlecht
F
Eingang
28.09.2022
Impfdatum
27.06.2022
Beginn
26.07.2022
Tage bis Beginn
29,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Granuloma Limb mass

Symptomtext

Mass of right thigh, granulomatous reaction to vaccine as determined by dermatologist (benign growth) Occurred a few weeks after vaccine given, no treatment or intervention deemed necessary at this time

Weitere VAERSDATA-Felder
Praegender Schweregrund
Granuloma
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2408263

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ600AA

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
11.08.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect product formulation administered Medication error No adverse event

Symptomtext

patient was administered ACTHIB that was not reconstituted with the supplied diluent and another diluent was used to reconstitute the vaccine with no reported adverse event; Initial information received on 29-Jul-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient of unknown demographics, and the patient was administered acthib (HIB (PRP/T) VACCINE) that was not reconstituted with the supplied diluent and another diluent was used to reconstitute the vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect HIB (PRP/T) VACCINE (formulation, strength, route: unknown) lot UJ600AA, expiration date: 30-Nov-2022, in unknown administration site as Immunization. On an unknown date the patient was administered acthib that was not reconstituted with the supplied diluent and another diluent was used to reconstitute the vaccine with no reported adverse event (incorrect product formulation administered) (unknown latency) following the administration of HIB (PRP/T) VACCINE. The patient was administered ACTHIB that was reconstituted with another diluent other than the supplied 0.4% Sodium Chloride ACTHIB diluent. Caller stated that she was doing inventory and there was an extra diluent left in the box, so she thinks that someone must have used another diluent to reconstitute the ACTHIB. She was not sure which alternative diluent was used and did not know which patient received the vaccine. This situation was reported as a medication error due to a patient being administered ACTHIB that was not reconstituted with the supplied diluent and another diluent was used to reconstitute the vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-